In breast cancer induced by MMTV-Wnt1 in mice and in human breast cancer cell lines in vitro, it was shown that doxorubicin treatment results in senescence induction in p53 wild-type tumors and in apoptosis in p53-deficient tumors (54). This evidence concerns the gene TP53 and breast cancer.